GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh

Ema G. Rodrigues, Molly Kile, Elaine Hoffman, Quazi Quamruzzaman, Mahmuder Rahman, Golam Mahiuddin, Yumei Hsueh, David C. Christiani

研究成果: 雜誌貢獻文章

24 引文 (Scopus)

摘要

We determined whether single nucleotide polymorphisms (SNPs) in the glutathione S-transferase omega (GSTO) and arsenic(III)methyltransferase (AS3MT) genes were associated with concentrations of urinary arsenic metabolites among 900 individuals without skin lesions in Bangladesh. Four SNPs were assessed in these genes. A pathway analysis evaluated the association between urinary arsenic metabolites and SNPs. GSTO1 rs4925 homozygous wild type was significantly associated with higher monomethylarsonic acid (MMA) and dimethylarsinic acid urinary concentrations, whereas wild-type AS3MT rs11191439 had significantly lower levels of AsIII and MMA. Genetic polymorphisms GSTO and As3MT modify arsenic metabolism as evidenced by altered urinary arsenic excretion.

原文英語
頁(從 - 到)240-247
頁數8
期刊Biomarkers
17
發行號3
DOIs
出版狀態已發佈 - 五月 2012

指紋

Bangladesh
Arsenic
Genetic Polymorphisms
Glutathione Transferase
Polymorphism
Single Nucleotide Polymorphism
Nucleotides
Metabolites
Genes
Cacodylic Acid
Methyltransferases
Metabolism
Skin

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

引用此文

Rodrigues, E. G., Kile, M., Hoffman, E., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., ... Christiani, D. C. (2012). GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh. Biomarkers, 17(3), 240-247. https://doi.org/10.3109/1354750X.2012.658863

GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh. / Rodrigues, Ema G.; Kile, Molly; Hoffman, Elaine; Quamruzzaman, Quazi; Rahman, Mahmuder; Mahiuddin, Golam; Hsueh, Yumei; Christiani, David C.

於: Biomarkers, 卷 17, 編號 3, 05.2012, p. 240-247.

研究成果: 雜誌貢獻文章

Rodrigues, EG, Kile, M, Hoffman, E, Quamruzzaman, Q, Rahman, M, Mahiuddin, G, Hsueh, Y & Christiani, DC 2012, 'GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh', Biomarkers, 卷 17, 編號 3, 頁 240-247. https://doi.org/10.3109/1354750X.2012.658863
Rodrigues, Ema G. ; Kile, Molly ; Hoffman, Elaine ; Quamruzzaman, Quazi ; Rahman, Mahmuder ; Mahiuddin, Golam ; Hsueh, Yumei ; Christiani, David C. / GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh. 於: Biomarkers. 2012 ; 卷 17, 編號 3. 頁 240-247.
@article{5af27e3003f84f82ac48537187853593,
title = "GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh",
abstract = "We determined whether single nucleotide polymorphisms (SNPs) in the glutathione S-transferase omega (GSTO) and arsenic(III)methyltransferase (AS3MT) genes were associated with concentrations of urinary arsenic metabolites among 900 individuals without skin lesions in Bangladesh. Four SNPs were assessed in these genes. A pathway analysis evaluated the association between urinary arsenic metabolites and SNPs. GSTO1 rs4925 homozygous wild type was significantly associated with higher monomethylarsonic acid (MMA) and dimethylarsinic acid urinary concentrations, whereas wild-type AS3MT rs11191439 had significantly lower levels of AsIII and MMA. Genetic polymorphisms GSTO and As3MT modify arsenic metabolism as evidenced by altered urinary arsenic excretion.",
keywords = "Arsenic metabolism, Drinking water, Pathway analysis",
author = "Rodrigues, {Ema G.} and Molly Kile and Elaine Hoffman and Quazi Quamruzzaman and Mahmuder Rahman and Golam Mahiuddin and Yumei Hsueh and Christiani, {David C.}",
year = "2012",
month = "5",
doi = "10.3109/1354750X.2012.658863",
language = "English",
volume = "17",
pages = "240--247",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - GSTO and AS3MT genetic polymorphisms and differences in urinary arsenic concentrations among residents in Bangladesh

AU - Rodrigues, Ema G.

AU - Kile, Molly

AU - Hoffman, Elaine

AU - Quamruzzaman, Quazi

AU - Rahman, Mahmuder

AU - Mahiuddin, Golam

AU - Hsueh, Yumei

AU - Christiani, David C.

PY - 2012/5

Y1 - 2012/5

N2 - We determined whether single nucleotide polymorphisms (SNPs) in the glutathione S-transferase omega (GSTO) and arsenic(III)methyltransferase (AS3MT) genes were associated with concentrations of urinary arsenic metabolites among 900 individuals without skin lesions in Bangladesh. Four SNPs were assessed in these genes. A pathway analysis evaluated the association between urinary arsenic metabolites and SNPs. GSTO1 rs4925 homozygous wild type was significantly associated with higher monomethylarsonic acid (MMA) and dimethylarsinic acid urinary concentrations, whereas wild-type AS3MT rs11191439 had significantly lower levels of AsIII and MMA. Genetic polymorphisms GSTO and As3MT modify arsenic metabolism as evidenced by altered urinary arsenic excretion.

AB - We determined whether single nucleotide polymorphisms (SNPs) in the glutathione S-transferase omega (GSTO) and arsenic(III)methyltransferase (AS3MT) genes were associated with concentrations of urinary arsenic metabolites among 900 individuals without skin lesions in Bangladesh. Four SNPs were assessed in these genes. A pathway analysis evaluated the association between urinary arsenic metabolites and SNPs. GSTO1 rs4925 homozygous wild type was significantly associated with higher monomethylarsonic acid (MMA) and dimethylarsinic acid urinary concentrations, whereas wild-type AS3MT rs11191439 had significantly lower levels of AsIII and MMA. Genetic polymorphisms GSTO and As3MT modify arsenic metabolism as evidenced by altered urinary arsenic excretion.

KW - Arsenic metabolism

KW - Drinking water

KW - Pathway analysis

UR - http://www.scopus.com/inward/record.url?scp=84860380361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860380361&partnerID=8YFLogxK

U2 - 10.3109/1354750X.2012.658863

DO - 10.3109/1354750X.2012.658863

M3 - Article

C2 - 22339537

AN - SCOPUS:84860380361

VL - 17

SP - 240

EP - 247

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 3

ER -